Stichting Administratiekantoor Westend
SEC CIK 1460840 · EDGAR
BoughtSold
Most active insiders at LXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Artal Group S.A. | Dir, 10% | $2.00M | — |
| 2 | DEBBANE RAYMOND | Dir | $723.0K | — |
| 3 | Martens Rachel Yap | SVP, Partnerships, Corp Strat | — | — |
| 4 | Gopinathan Suma | SVP, Discovery | — | — |
| 5 | Artal Participations S.a r.l. | Dir, 10% | — | — |
| 6 | Cheung Ivan | Dir | — | — |
| 7 | Exton Michael | CEO, Dir | — | — |
| 8 | Sullivan Diane E. | Dir | — | — |
| 9 | McDermott Wendy | SVP, Human Resources | — | — |
| 10 | Granowitz Craig B | SVP, Chief Medical Off | — | — |
Stichting Administratiekantoor Westend made no open-market trades at LXRX in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-03-13 | 2024-03-13 | LXRX | LEXICON PHARMACEUTICALS, INC. | Stichting Administratiekantoor Westend | Dir, 10% | A - Grant | $108.50 | +1.15M | 1.15M | New | +$124.88M |
| 2022-10-27 | 2022-10-25 | SRRK | Scholar Rock Holding Corp | Stichting Administratiekantoor Westend | 10% | P - Purchase | $8.04 | +130.3K | 8.98M | +1% | +$1.05M |
Purchase Sale Sale after option exercise All abbreviations